TRIANA Biomedicines

TRIANA Biomedicines

Biotechnology Research

Lexington, Massachusetts 3,307 followers

TRIANA Biomedicines rationally designs Molecular Glue for high-value disease targets.

About us

TRIANA Biomedicines is a venture-backed biopharmaceutical company leading a transformative approach to discover and develop novel small molecules to treat disease. Our technology enables us to identify molecules that promote the interaction between a target and another protein in a way that alters the fate or function of the target protein. These innovative “molecular glues” allow us to treat disease in entirely new ways by pursuing highly disease relevant targets that have long been considered undruggable or are inadequately addressed. Our target-first, rational approach to molecular glue discovery lets us consider a wide-range of therapeutic applications for our products. Our initial focus on targeted protein degradation is driven by our desire to discover and develop groundbreaking new cancer medicines. TRIANA Biomedicines is headquartered in Waltham, Massachusetts, and has established internal laboratory work as well as key collaborations with academia and industry partners.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Lexington, Massachusetts
Type
Privately Held

Locations

  • Primary

    1050 Waltham St

    Suite 301

    Lexington, Massachusetts 02421, US

    Get directions

Employees at TRIANA Biomedicines

Updates

Similar pages

Browse jobs

Funding